IL17A and atherosclerosis: The principal molecular targets included AKT1, TP53, ESR1, CASPASE3, and BCL2, while the major enriched pathways involved PI3K–Akt, lipid and atherosclerosis, AGE–RAGE, MAPK, and IL-17 pathway.